Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease

被引:2
|
作者
Simbrunner, Benedikt [1 ,2 ,3 ]
Stadlmann, Alexander [1 ,2 ,4 ]
Schwabl, Philipp [1 ,2 ,3 ]
Paternostro, Rafael [1 ,2 ]
Bauer, David J. M. [1 ,2 ]
Bucsics, Theresa [1 ,2 ]
Scheiner, Bernhard [1 ,2 ]
Lampichler, Katharina [5 ]
Woeran, Katharina [6 ]
Beer, Andrea [6 ]
Eigenbauer, Ernst [7 ]
Pinter, Matthias [1 ]
Staettermayer, Albert-Friedrich [1 ]
Marculescu, Rodrig [8 ]
Szekeres, Thomas [8 ]
Trauner, Michael [1 ]
Mandorfer, Mattias [1 ,2 ,3 ]
Reiberger, Thomas [1 ,2 ,3 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fi, Vienna, Austria
[4] Hosp Hietzing, Vienna, Austria
[5] Med Univ Vienna, Dept Radiol, Vienna, Austria
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
[7] Med Univ Vienna, IT4Sci, Vienna, Austria
[8] Med Univ Vienna, Dept Lab Med, Vienna, Austria
关键词
Cirrhosis; HVPG; PLGF; SFLT1; Angiogenesis; Portal-hypertensive gastropathy;
D O I
10.1016/j.dld.2020.09.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Experimental data indicates that placental growth factor (PLGF) is involved in the pathophysiology of portal hypertension (PH) due to advanced chronic liver disease (ACLD). We investigated serum levels of PLGF and its "scavenger", the receptor soluble fms-like tyrosine kinase-1 (sFLT1, or sVEGFR1), in ACLD patients with different severity of PH and portal-hypertensive gastropathy (PHG). Methods: PLGF and sVEGFR1 were measured in ACLD patients with hepatic venous pressure gradient (HVPG) >= 6 mmHg (n = 241) and endoscopic evaluation of PHG (n = 216). Patients with pre-/posthepatic PH, TIPS, liver transplantation and hepatocellular carcinoma were excluded. Results: Thirty-two (13%) patients had HVPG 6-9 mmHg, 128 (53%) 10-19 mmHg and 81 (34%) 0.001) levels increased across HVPG strata, while PLGF/sVEGFR1 ratios remained similar (0.19 vs. 0.20 vs. 0.18 pg/mL; p = 0.140). The correlation between PLGF and HVPG was weak (Rho = 0.190,95%CI 0.06-0.31; p = 0.003), and the PLGF/sVEGFR1 ratio did not correlate with HVPG (p = 0.331). The area-under-the-receiver operating characteristics (AUROC) for PLGF to detect clinically significant PH (CSPH;i.e. HVPG 10 mmHg) yielded only 0.688 (0.60-0.78; p < 0.001). When compared to ACLD patients without PHG, PLGF levels (20 without vs. 21.4 with mild vs. 17.1 pg/mL with severe PHG, respectively; p = 0.005) and PLGF/sVEGFR1 ratios (0.20 vs. 0.19 vs. 0.17; p = 0.076) did not increase with mild and severe PHG. Conclusion: While PLGF levels tended to increase with severity of PH, the PLGF/sVEGFR1 ratio remained stable across HVPG strata. Neither PLGF nor the PLGF/sVEGFR1 ratio had diagnostic value for prediction of CSPH. The severity of PHG was also not associated with stepwise increases in PLGF levels or PLGF/sVEGFR1 ratio. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 50 条
  • [21] Secondary hyperaldosteronism and liver fibrosis in patients with compensated chronic liver disease or portal hypertension
    Vitale, Giovanni
    Coscia, Kimberly
    Zavatta, Guido
    Morelli, Maria Cristina
    Vicennati, Valentina
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 99 : 118 - 120
  • [22] Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease
    Mendoza, Yuly
    Cocciolillo, Sila
    Chen, Tianyan
    Margini, Cristina
    Sebastiani, Giada
    Berzigotti, Annalisa
    Murgia, Giuseppe
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (13) : 3017 - +
  • [23] Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension
    Peio Aristu-Zabalza
    María Andrés-Rozas
    Zoe Boyer-Díaz
    David P. Al-Adra
    Douglas Maya-Miles
    Sergi Guixé-Muntet
    Anabel Fernández-Iglesias
    Jordi Gracia-Sancho
    Biology of Sex Differences, 16 (1)
  • [24] Mildly Low Serum Sodium Levels in Chronic Liver Disease: At Risk for Sarcopenia and Portal Hypertension
    Nakamura, Atsushi
    Yoshimura, Tsubasa
    Ichikawa, Takeshi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [25] Pancreaticoduodenectomy with radical lymphadenectomy is not contraindicated for patients with established chronic liver disease and portal hypertension
    Harsheet Sethi
    Parthi Srinivasan
    Gabriele Marangoni
    Andreas Prachalias
    Mohamed Rela
    Nigel Heaton
    Hepatobiliary&PancreaticDiseasesInternational, 2008, (01) : 82 - 85
  • [26] Pancreaticoduodenectomy with radical lymphadenectorny is not contraindicated for patients with established chronic liver disease and portal hypertension
    Sethi, Harsheet
    Srinivasan, Parthi
    Marangoni, Gabriele
    Prachalias, Andreas
    Rela, Mohamed
    Heaton, Nigel
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2008, 7 (01) : 82 - 85
  • [27] Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
    Simbrunner, Benedikt
    Marculescu, Rodrig
    Scheiner, Bernhard
    Schwabl, Philipp
    Bucsics, Theresa
    Stadlmann, Alexander
    Bauer, David J. M.
    Paternostro, Rafael
    Eigenbauer, Ernst
    Pinter, Matthias
    Staettermayer, Albert Friedrich
    Trauner, Michael
    Mandorfer, Mattias
    Reiberger, Thomas
    LIVER INTERNATIONAL, 2020, 40 (07) : 1713 - 1724
  • [28] Influence of Gut-Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management
    Santopaolo, Francesco
    Coppola, Gaetano
    Giuli, Lucia
    Gasbarrini, Antonio
    Ponziani, Francesca Romana
    MICROBIOLOGY RESEARCH, 2022, 13 (03) : 539 - 555
  • [29] Rheumatoid arthritis treated with tocilizumab in two patients with complicated chronic liver disease with portal hypertension
    Amouzougan, Adamah
    Denarie, Delphine
    Marotte, Hubert
    Roblin, Xavier
    Thomas, Thierry
    JOINT BONE SPINE, 2018, 85 (01) : 105 - 107
  • [30] Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study
    Robic, Marie Angele
    Procopet, Bogdan
    Metivier, Sophie
    Peron, Jean Marie
    Selves, Janick
    Vinel, Jean Pierre
    Bureau, Christophe
    JOURNAL OF HEPATOLOGY, 2011, 55 (05) : 1017 - 1024